NOD2 and Sacroiliac arthritis: Non-HLA polymorphisms such as nucleotide-binding oligomerization domain-containing protein 2 (NOD2) polymorphisms increase the risk of CD about 4–40 times and is associated with sacroiliitis amongst patients with IBD.